Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2023-04-28 | Mr. Viehbacher has extensive international experience in both large pharmaceutical companies and entrepreneurial biotech companies. He brings a keen understanding of the complexities involved in running a multibillion-dollar global pharmaceutical business. |
| 2024-04-26 | Education: B. Comm. from Queen’s University (Kingston, Canada). |
Data sourced from SEC filings. Last updated: 2025-08-30